In addition to AT patients with biallelic variants, germline carriers of one copy of the altered ATM have a several-fold higher predisposition to cancer than the general population (e.g., breast cancer; MIM#114480) (Swift et al., 1991). The gene discussed is ATM; the disease is ataxia telangiectasia.